[go: up one dir, main page]

AU2001231030A1 - Inhibitors of protease-activated receptor-2 (par-2) as novel asthma therapeutics - Google Patents

Inhibitors of protease-activated receptor-2 (par-2) as novel asthma therapeutics

Info

Publication number
AU2001231030A1
AU2001231030A1 AU2001231030A AU3103001A AU2001231030A1 AU 2001231030 A1 AU2001231030 A1 AU 2001231030A1 AU 2001231030 A AU2001231030 A AU 2001231030A AU 3103001 A AU3103001 A AU 3103001A AU 2001231030 A1 AU2001231030 A1 AU 2001231030A1
Authority
AU
Australia
Prior art keywords
par
protease
inhibitors
activated receptor
asthma therapeutics
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001231030A
Inventor
Victor E. Barrios
Clifford D. Wright
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Amgen Inc
Original Assignee
Amgen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amgen Inc filed Critical Amgen Inc
Publication of AU2001231030A1 publication Critical patent/AU2001231030A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU2001231030A 2000-01-20 2001-01-19 Inhibitors of protease-activated receptor-2 (par-2) as novel asthma therapeutics Abandoned AU2001231030A1 (en)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US17713700P 2000-01-20 2000-01-20
US60177137 2000-01-20
US20335700P 2000-05-10 2000-05-10
US60203357 2000-05-10
US72840400A 2000-11-28 2000-11-28
US09728404 2000-11-28
PCT/US2001/001968 WO2001052883A1 (en) 2000-01-20 2001-01-19 Inhibitors of protease-activated receptor-2 (par-2) as novel asthma therapeutics

Publications (1)

Publication Number Publication Date
AU2001231030A1 true AU2001231030A1 (en) 2001-07-31

Family

ID=27390781

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001231030A Abandoned AU2001231030A1 (en) 2000-01-20 2001-01-19 Inhibitors of protease-activated receptor-2 (par-2) as novel asthma therapeutics

Country Status (2)

Country Link
AU (1) AU2001231030A1 (en)
WO (1) WO2001052883A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002352382A1 (en) * 2001-12-13 2003-06-23 Kowa Company Ltd Use of protease-activated receptor-2 inhibitor in the manifacture of a medicament for treating delayed hypersensitivity
WO2004002418A2 (en) * 2002-06-26 2004-01-08 Entremed, Inc Compositions and methods comprising protein activated receptor antagonists
US7498322B2 (en) 2004-03-12 2009-03-03 Entremed, Inc. Antiangiogenic agents
US7888482B2 (en) 2006-02-10 2011-02-15 Amgen Inc. Antibodies that bind PAR-2
CL2008001887A1 (en) 2007-06-29 2008-10-03 Amgen Inc PROTEINS OF UNION TO ANTIGEN THAT JOIN THE RECEPTOR ACTIVATED BY PROTEASES 2 (PAR-2); NUCLEIC ACID THAT CODES THEM; VECTOR AND GUEST CELL; METHOD OF PRODUCTION; AND COMPOSITION THAT UNDERSTANDS THEM.
JP5883863B2 (en) 2010-07-28 2016-03-15 ザ ユニバーシティ オブ クィーンズランド Protease-activated receptor modulator

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH06228000A (en) * 1993-01-28 1994-08-16 Teijin Ltd Medicine for improving airway obstruction
US5633227A (en) * 1994-09-12 1997-05-27 Miles, Inc. Secretory leukocyte protease inhibitor as an inhibitor of tryptase
CN1160398A (en) * 1994-09-23 1997-09-24 阿瑞斯药物公司 Compositions and methods for treating mast-cell inflammatory condition
US5888529A (en) * 1997-03-28 1999-03-30 The Regents Of The University Of California Ileus treatment method
KR20010006119A (en) * 1997-04-07 2001-01-26 액시스 파마슈티컬스 인코포레이티드 Compounds and compositions for treating diseases associated with serine protease, particularly tryptase, activity
US20010006939A1 (en) * 1997-10-03 2001-07-05 Ralph W. Niven Secretory leukocyte protease inhibitor dry powder pharmaceutical compositions

Also Published As

Publication number Publication date
WO2001052883A1 (en) 2001-07-26

Similar Documents

Publication Publication Date Title
AU2002245718A1 (en) Methods for modifying flowering phenotypes
AU2001294932A1 (en) Ethers of 7-desmethylrapamycin for use in immunosuppression
AU2002216087A1 (en) Novel substituted imidazotriazinones as pde ii-inhibitors
AU2002224808A1 (en) Use of thienopyrimidines
AU2002235326A1 (en) Processes for large scale production of tetrapyrroles
AU2003208595A1 (en) Process for the preparation of pure silica
AU2001259817A1 (en) Methods of and compounds for inhibiting calpains
AU2001273762A1 (en) Process for the preparation of (r)-2-alkyl-3-phenyl-1-propanols
AU2001231030A1 (en) Inhibitors of protease-activated receptor-2 (par-2) as novel asthma therapeutics
AU2002300166A1 (en) Process for the Preparation of Peptides
AU2002225796A1 (en) Tablet form of gas generant
AU2002235166A1 (en) Chromatographic processes for recovery of isosorbide
AU2002227035A1 (en) Methods of stabilizing fruit-concentrate powders
AU2002224835A1 (en) Dihydroisoquinolines as novel phosphodiesterase inhibitors
AU2002350912A1 (en) Electrode structure for protection of structural bodies
AU2000261768A1 (en) An improved process for the preparation of docetaxel
AU2003256006A1 (en) Improved process for preparation of risperidone
AU2002213477A1 (en) Process for preparation of n-substituted 2-sulfanylimidazoles
AU2002222687A1 (en) Process for preparation of polyhydric alcohols
AU2002350018A1 (en) Mixture of abrasive particles with different toughness
AU5462901A (en) Process for the preparation of (pyridinylidene)-phthalides
AU2003274794A1 (en) In vitro flowering method for roses
AU2001241042A1 (en) Process for the preparation of hydrazine derivatives
AU6428201A (en) Process for the preparation of 1-substituted-cyclo-hexanecarbonyl halides
AU2002360614A1 (en) Methods of inhibiting fertility